Liberty Defense Commends Department of Homeland Security’s TSA Modernization Initiative

(TSX-V:SCAN),(OTC US:LDDFF),(Other OTC:LDDFF),(Boerse Frankfurt – Freiverkehr:E30),(Boerse Frankfurt – Freiverkehr:LD2A), WILMINGTON, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE: E30), a leading technology provider of Artificial Intelligence (AI)-based next generation detection solutions for concealed weapons and threats, today announced its support and commendation of […]

Servus Credit Union welcomes economist Charles St-Arnaud as Chief Economist

EDMONTON, Alberta, Nov. 26, 2025 (GLOBE NEWSWIRE) — Servus Credit Union Ltd. (Servus) today announced that economist Charles St-Arnaud will be joining the organization on Dec. 1 as Chief Economist, bringing an established economist function into Servus and strengthening its ability to deliver clear, data-driven insight for members and Albertans. Charles previously served as Chief

Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it has entered into an exclusive licensing and commercialization agreement with RK Pharma Inc of the US for a novel sterile injectable 505(b)(2) oncology supportive care product for the US market. https://mma.prnewswire.com/media/2592545/5350910/Zydus_Lifesciences_Limited_Logo.jpg Under the terms of this agreement, RK

Global Uranium Announces Strategic Expansion of Airline Project Claims in Wyoming

(CNSX:GURN.CN),(OTC US:GURFF),(Other OTC:GURFF),(Boerse Frankfurt – Freiverkehr:Q3J), CALGARY, Alberta, Nov. 26, 2025 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company“) is pleased to announce that it has expanded its land position at the Airline Project, located within the Copper Mountain uranium district of Wyoming. The new claims (Figure

Apolosign Launches Black Friday Sale Offering Up to 30% OFF Plus $50 Off Every Order — The Lowest Prices of 2025

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — As American households gear up for the year's biggest shopping week, Apolosign is introducing a more connected, visual, and family-friendly way to stay organized. The brand is unveiling a complete home schedule management solution–built around its wall-mounted Digital Calendar, portable TVs, and high-resolution digital photo frames–just as

Canon Medical Secures FDA Clearance for Ultrasound Innovations, Advancing Image Clarity and Workflow Efficiency

Tustin, Ca, Nov. 26, 2025 (GLOBE NEWSWIRE) — Canon Medical Systems USA, Inc. recently received FDA 510(k) clearance for its Aplio i-series diagnostic ultrasound systems (Aplio i900, Aplio i800, and Aplio i700) with Software Version 9.0. This clearance introduces advanced imaging technologies designed to help clinicians achieve high-quality diagnostic images with greater efficiency. The new

Design Therapeutics to Participate in Upcoming Investor Conferences

(NASDAQ:DSGN), CARLSBAD, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in fireside chats at the following upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 3:30 p.m. ET

Vera Bradley, Inc. Announces Reporting Date for Third Quarter Fiscal Year 2026 Results

(NASDAQ:VRA), FORT WAYNE, Ind., Nov. 26, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced that it plans to report results for the third quarter ending November 1, 2025 of fiscal year 2026 (fiscal year ending January 31, 2026) at 8:00 a.m. Eastern Time on Thursday, December 11, 2025. The Company

Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference

(NASDAQ:KRYS), PITTSBURGH, Nov. 26, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 8th Annual Evercore Healthcare Conference on December 3, 2025, in Miami. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:00 am ET

REMINDER — Rogers Sugar Inc.: Conference Call – 4th Quarter 2025 Results

(TSX:RSI), MONTREAL, Nov. 26, 2025 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2025 fourth quarter results on Thursday, November 27, 2025, at 8:00 a.m. (Eastern Time). The conference call will be chaired by Mr. Michael Walton, Chief Executive Officer and Mr. Jean-Sebastien Couillard, Chief Financial Officer.

Scroll to Top